[Hemorrheological survey in a group with arteriosclerotic vascular disease treated with suloctidil]

G Caimi; A Catania; F Frazzetta; D Capobianco; G Francavilla; A Romano; A Sarno

[Hemorrheological survey in a group with arteriosclerotic vascular disease treated with suloctidil]

Ric Clin Lab. 1983:13 Suppl 3:465-8.

[Article in Italian]

Authors

G Caimi, A Catania, F Frazzetta, D Capobianco, G Francavilla, A Romano, A Sarno

PMID: 6324326

Abstract

In 17 patients affected by atherosclerotic vascular disease and showing in basal conditions a hyperviscosity state, we have monitored the main hemorheological determinants during treatment with Suloctidil. At the end of treatment carried out for 5 months the results showed that erythrocyte filterability was the only hemorheological determinant influenced. The possible causes of this action are therefore considered.

Publication types

English Abstract

MeSH terms

Aged
Arterial Occlusive Diseases / blood
Arterial Occlusive Diseases / drug therapy*
Blood Viscosity*
Erythrocytes / physiology
Female
Fibrinogen / analysis
Hematocrit
Humans
Intracranial Arteriosclerosis / blood
Intracranial Arteriosclerosis / drug therapy*
Leg / blood supply
Male
Middle Aged
Propanolamines / therapeutic use*
Rheology
Suloctidil / therapeutic use*

Substances

Propanolamines
Fibrinogen
Suloctidil